Latest kidney cancer news
New treatment, casdatifan, shows promise in previously treated kidney cancer
A new treatment called casdatifan showed promising responses in a [...]
Bevacizumab plus erlotinib shows antitumor activity in advanced papillary kidney cancer
A recent phase 2 study, published in the New England [...]
Coalition for Reducing Bureaucracy in Clinical Trials 2025 Recommendations
All medicines need to pass rigorous tests before they can [...]
Kidney cancer cases are projected to double by 2050
Lifestyle risk factors such as obesity, smoking, lack of exercise, [...]
Cancer waiting times: Latest updates
Recent years have seen pressure on NHS cancer services increase, [...]
First NICE guideline on kidney cancer
A new draft guideline, issued by the National Institute for [...]
Most used tags
renal cell carcinoma immunotherapy combination therapy checkpoint inhibitors Cancer nivolumab TKIs overall survival kidney cancer Opdivo sunitinib cabozantinib Sutent progression-free survival NHS England biomarkers ipilimumab pembrolizumab Cabometyx axitinib COVID-19 cancer survival non-clear cell kidney cancer VEGF inhibitors Inlyta coronavirus risk factors Yervoy adjuvant therapy Keytruda targeted therapy metastases papillary RCC everolimus biological markers ASCO Afinitor cancer outcomes first-line treatment NICEArchives
- 2025: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2024: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2023: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2022: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2021: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2020: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2019: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2018: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2017: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2016: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
